NewsRoom Articles - Page 106 of 239

ThursdayMar 02, 2023 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Nano-sized Molecules Show Powerful Impact in Preclinical Studies

BiondVax Pharmaceuticals is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products The company’s alpaca-derived nanosized antibodies (“NanoAbs”) exhibit superior valuable competitive advantages over commercially available monoclonal antibodies (“mAbs”), including better specificity and affinity to the target, hyper-thermostability, and potential for more effective and convenient routes of administration Preclinical in vivo data have shown its lead drug candidate, the inhaled anti-SARS-CoV-2 NanoAb, led to a significantly shorter and milder illness, virtually eliminated the virus from the lungs, and effectively prevented illness when administered prophylactically BiondVax aims to fill the void in COVID-19 therapeutics and is forging ahead…

WednesdayMar 01, 2023 11:09 am

Study Finds Chronic Pain Increases Risk of Developing Dementia

Chronic pain is a long-standing pain that occurs together with another chronic illness such as arthritis or cancer. Chronic pain has been linked to depression, anxiety, restrictions in mobility and daily activities, increased health care costs, poor quality of life and dependence on opioids. Now, new research has found that an individual’s risk of cognitive decline and dementia heightens if they suffer from chronic pain that lasts for more than three months. The study was carried out by researchers at the Chinese Academy of Sciences in Beijing. Professor Tu Yiheng, who was the study’s corresponding author, is a psychology professor…

TuesdayFeb 28, 2023 12:50 pm

Researchers Find Balancing Ability May Predict Risk of Cognitive Decline

Investigators at the University of Tsukuba have discovered that physical balance can be used to predict an individual's risk of mild cognitive impairment and Alzheimer’s disease (AD). The researchers found that physicians may be able to identify patients who have higher chances of developing the neurological disease by measuring their physical balance. Alzheimer’s disease is usually precipitated by mild cognitive impairment, a condition that results in a minor decline in cognitive function. This stage of cognitive decline is characterized by problems with memory, judgment or language and is usually followed by severe cognitive decline if left untreated. Given that the…

MondayFeb 27, 2023 12:24 pm

Risk Factors of Age-Related Macular Degeneration

Age-related macular generation is an ocular disease that causes a reduction in central vision as individuals grow older. The condition is caused when a region of the retina called the macular becomes damaged and causes patients to lose the ability to see fine details; it can also be referred to as central vision. While age-related macular degeneration (ARMD) rarely causes blindness, it is the number one cause of severe eyesight loss in people aged 50 and above. Individuals suffering from the advanced stages of this ailment often lose the ability to see faces, drive and read the small print. By…

FridayFeb 24, 2023 11:05 am

Study Finds Eczema Cases Increasing Among Children

Eczema is a condition that causes an individual’s skin to become dry, itchy and cracked; in some cases, skin can even ooze. Some types of eczema, such as dyshidrotic eczema, can cause blisters. Data from the National Eczema Association indicates more than 31 million individuals in the U.S. suffer from eczema. While it can flare up at any age, this chronic skin condition is common in young children. It is estimated that about 9.6 million children below 18 years of age suffer from atopic dermatitis. Experts believe that this skin condition is more prevalent in higher-income areas, which are more…

FridayFeb 24, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) and Its Collaborators Are Positioned to Rapidly Develop COVID-19 Treatments to Neutralize Emerging Variants

BiondVax is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products The company primarily targets infectious diseases and autoimmune diseases, with its lead candidate, an inhaled COVID-19 NanoAb therapy, the subject of preclinical studies So far, the preclinical studies have shown that the NanoAb results in significantly milder illness and faster recovery, eliminates the SARS-CoV-2 virus from the lungs, and prevents illness when administered prophylactically The FDA has revoked the authorization of multiple mAb treatments and one mAb prophylactic drug, creating a significant gap in a market that has shown strong demand for COVID-19 treatments BiondVax is…

ThursdayFeb 23, 2023 2:14 pm

Researchers Find Ways to Ease Cancer Treatment Outcome Prediction

Immunotherapy is one of the newest cancer treatment options that has made it possible for physicians to target and treat cancer more effectively. This treatment works by helping a patient’s immune system to kill cancer cells rather than using pharmaceuticals or radiation therapy to directly fight the cancer cells. Immunotherapy typically has fewer side effects compared to other cancer treatment options, and it can be used on cancers such as skin cancer, which don’t respond well to other treatments, including chemotherapy, and it may prevent cancer from returning by boosting the immune system’s ability to fight cancer cells. However, immunotherapies…

WednesdayFeb 22, 2023 11:24 am

Consuming Too Much Salt May Trigger Autoimmune Illnesses

Consuming too much salt affects an individual’s cardiovascular system and blood pressure negatively while also impacting the immune system adversely. A new study has now found that the consumption of too much salt weakens the energy supply of regulatory T cells, preventing them from working properly. Regulatory T cells are cells that help maintain homeostasis in the body by suppressing immune responses that may cause excessive inflammation. The study was carried out by a global team of researchers coordinated by researchers at the Max Delbrück Center in Germany, Hasselt University and the VIB Center for Inflammation Research in Belgium. A…

WednesdayFeb 22, 2023 9:45 am

Silo Pharma Inc. (NASDAQ: SILO) Granted US Patent For SPC-15 to Prevent and Treat Stress-Induced Disorders

SILO issued US Patent by USPTO titled “Pharmacological Prophylactics Against Stress-Induced Affective Disorders In Females” Claims allowed by patent protect use of SPC-15 for treating stress-induced affective disorders, including anxiety and PTSD Other therapeutics in company pipeline include SPU-16 to treat multiple sclerosis, SPU-21 to treat rheumatoid arthritis, SPC-14 to treat Alzheimer’s disease Therapeutics developed by SILO may qualify for FDA’s streamlined 505(b)(2) regulatory drug approval pathway Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, was recently issued US Patent 11,491,120 by the US Patent and Trademark Office (“USPTO”) (https://ibn.fm/rMLOR). The…

WednesdayFeb 22, 2023 9:00 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) NanoAb Product Shows Preclinical Promise as COVID Preventative for consumers Hit by Evusheld’s EUA Withdrawal

BiondVax Pharmaceuticals is promoting preclinical results of its lead “biobetter” NanoAb drug candidate for conveniently proactively preventing COVID The company’s CEO recently presented the data at the annual BIO CEO & Investor Conference in New York, as well as updates on the company’s pipeline for treating autoimmune diseases such as psoriasis, asthma, psoriatic arthritis and macular degeneration Monoclonal antibody-based drug product Evusheld recently lost its EUA authorization as a COVID preventative after FDA findings that it insufficiently protects against the current wOmicron sub-variants, eliminating the only preventative option for vaccine-intolerant patients BiondVax nano-sized antibodies may provide superior responses to COVID…